Upstream Bio, Inc. (($UPB)) announced an update on their ongoing clinical study. Upstream Bio, Inc. is conducting a study titled ‘A Long-Term ...

Teva Pharmaceuticals has agreed to pay $35 million and withdraw six patents from a U.S. regulatory list to settle claims that the drugmaker delayed generic competition for its QVAR asthma inhalers, ...

Patients who depended on oral corticosteroids to care for their severe asthma experienced improvements in asthma control ...

Mepolizumab significantly reduced healthcare resource utilization, including hospitalizations and emergency department visits, in patients with severe eosinophilic asthma over two years. The treatment ...

Elinzanetant provides a hormone-free treatment option for vasomotor symptoms by targeting the brain's thermoregulatory center. Elinzanetant offers a hormone-free solution for managing ...

Ethical and statistical power issues limit the use of randomized controlled trials to study medication and vaccine use during ...